Thank you Ana I. Velázquez Mañana, MD, MSc, FASCO for having the courage to talk about this important question— why are women leaving their current institution? Happening now in S404 @ASCO23 Fumiko Ladd Chino, MD, FASCO #womeninmedicine

#ASCO23 Plenary presentation by Roy Herbst of ADAURA shows impressive OS improvement. Far exceeds my own expectations. Cannot over-emphasize the importance of this finding for patients and their care team. Hope for global uptake and reimbursement. ASCO

Good morning day 4 of #ASCO23! Unadvertised perk of conference at McCormick is easy access to the lake for a morning run

Happening now in S501 @ASCO23. Navigating funding as a #juniorinvestigator — “the only way to do this is persistence.” Ana I. Velázquez Mañana, MD, MSc, FASCO Filipa Lynce, MD, FASCO Rafeh Naqash, MD Allison Betof Warner, MD, PhD Ramy Sedhom, MD

“The way to address cancer disparities is community engagement” — fantastic and practical talk by Cary Gross in mitigating disparities in cancer screening. Let’s get to work 💪🏽 @ASCO23 Amy L. Cummings, MD PhD

Congrats to @HemoncUcsf fellow Howard Lee, MD on his Conquer Cancer, the ASCO Foundation Merit Award and Lens Study poster presentation on frailty among older adults with lung cancer! #gerionc

One of my favorite parts of conferences is running into old friends! Excellent work by Jingyi Liu, MD, MBA at @ASCO23 in clinical trial #disparities StanfordMedRes Stanford Internal Medicine Chiefs

Thank you to Melissa (Kah Poh) Loh, MBBCh BAO, MS, FACCC for your dedicated mentorship through all of it!

Dr. Jones opening Day 2 of Butler Williams with an important discussion of the Health Disparities Research Framework. Thrilled to be part of this thought-provoking program. Special thank you to Melisa Wong, MD, MAS, AGSF for the mentorship in getting me here. #NIA #NIHAging #equity

Always wanted to go to Hawaii? Now’s your chance. Join #lungcancer experts at the 2nd Annual Hawaii Lung on January 20. Register now and see in you Honolulu: bit.ly/3QXNUHm #gotoPER #HLC24 #lcsm David Gandara Roy Herbst Heather Wakelee

Hawaii in January with #lungcancer experts — can a conference get any better? Oh my, yes it can, with free registration! #gotoPER #HLC24 #lcsm

After a day of lively discussion at Hawaii Lung, nothing like good views and company with these women in thoracic oncology. PER University of Hawaii Cancer Center Erminia Massarelli Anne Chiang Thank you to the chairs Roy Herbst Heather Wakelee David Gandara for organizing!

Thank you IASLC for bringing together this group of inspiring and dedicated women #TTLC24 Charu Aggarwal, MD, MPH, FASCO Heather Wakelee Meera Ragavan, MD MPH

Nothing like this view ☀️for a quick way to stretch the legs during day 3 of #TTLC24 IASLC Joel W. Neal, MD, PhD Charu Aggarwal, MD, MPH, FASCO

Apparently StanfordMedRes is good at creating thoracic oncologists! Stanford Internal Medicine Chiefs Sarah Waliany, MD, MS Ronald Witteles Meera Ragavan, MD MPH Divya Gupta, MD

Best part of conferences is connecting with colleagues, past and present. Thank you to Binaytara Foundation for bringing us all together for Napa Lung 2024 and Heather Wakelee for opening your home! Mohana Roy, MD Millie Das MD Matthew Gubens Joel W. Neal, MD, PhD Allison Betof Warner, MD, PhD Jackie Aredo Jonathan Riess, MD MS

🤩🔥Delighted to share our editorial with this stellar team, talking about the role of liquid biopsy in the sustained progression of precision oncology. Also highlighted in the presentation by our committee chair Carolina Reduzzi today at the International Society of Liquid Biopsy 20th year anniversary

Thank you to Cancer and Aging Research Group (CARG) #GeriOnc for connecting me with Melissa (Kah Poh) Loh, MBBCh BAO, MS, FACCC, who has been such a thoughtful and insightful mentor! #gerionc Supriya Mohile Richard Dunne, MD

Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors just out on Critical Reviews in Oncology Hematology (CROH) Circulating tumor cells (CTCs) 🔬have emerged as significant prognostic biomarkers across various solid tumors, with recent studies